Filing Flows

Filing Flows › Medtronic (MDT) › Recalls, complaints & regulation

Medtronic (MDT): recalls, EPA violations and clinical trials

Medtronic (MDT) beyond its filings: 70 recalls in the last 12 months (432 in five years, 154 Class I); 3 EPA-regulated facilities in violation, $118K in penalties over five years; 101 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
MEDTRONICEatontown Boro, NJViolation Identified—
COVIDIEN LPAugusta, GAViolation Identified—
COVIDIENNorfolk, NEViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Medtronic's latest quarter

Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.

Questions

Has Medtronic had any recalls?

432 recalls on file over five years from the FDA, CPSC and NHTSA; 70 in the last 12 months.

Has Medtronic been fined by the EPA?

The 91 EPA-regulated facilities on file under its name drew $118K in penalties over five years; 3 are in violation now.

How many clinical trials does Medtronic have?

101 active studies on ClinicalTrials.gov, 1 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.